OverviewChartNewsTraderScreen

Seer Inc/  US81578P1066  /

IEX
2024-04-19  9:59:50 PM Chg. -0.09 Volume Bid- Ask- High Low
1.67USD -4.84% 33,470
Turnover: 56,110.91		 -Bid Size: - -Ask Size: - 1.74 1.64
GlobeNewswire 04-11 Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreati...
GlobeNewswire 04-04 Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-24...
GlobeNewswire 04-02 FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metast...
GlobeNewswire 02-29 Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
GlobeNewswire 02-21 Seer to Participate in the TD Cowen 44th Annual Health Care Conference
GlobeNewswire 02-16 Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma
GlobeNewswire 02-12 Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR...
GlobeNewswire 02-06 Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance...
GlobeNewswire 02-01 Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
GlobeNewswire 01-04 First Patient Dosed in Trial Evaluating Efti and the Anti-PD-L1 Therapy BAVENCIO® in Metastatic Urot...
GlobeNewswire 2023-12-21 Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
GlobeNewswire 2023-12-21 BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Can...
GlobeNewswire 2023-12-12 Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer
GlobeNewswire 2023-11-10 Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
GlobeNewswire 2023-11-09 HUTCHMED Announces that Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously...
GlobeNewswire 2023-11-08 Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technolog...
GlobeNewswire 2023-11-07 Seer Reports Third Quarter 2023 Financial Results
GlobeNewswire 2023-11-06 Sermonix Pharmaceuticals Announces JCO Precision Oncology Publication of Case Report on a Complete R...
GlobeNewswire 2023-11-03 Candel Therapeutics Announces Initial Positive Interim Data from Randomized Phase 2 Clinical Trial o...
GlobeNewswire 2023-11-02 SEER’S MV TECHNOLOGIES RECEIVES NEW CONTRACTS FOR $1.5MM AND INCREASES ANNUAL MEDIA SUPPLY CONTRACTS
GlobeNewswire 2023-11-01 Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program
GlobeNewswire 2023-10-23 Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor Platform Presented at AACR Special Conf...
GlobeNewswire 2023-10-19 Seer to Report Third Quarter 2023 Financial Results on November 7, 2023
GlobeNewswire 2023-10-01 Global Communities Rally around Third Deadliest Cancer – Liver Cancer
GlobeNewswire 2023-09-20 World Leaders in Proteomics and Genomics to Convene at the 2nd International Top-Down Proteomics Sym...